A threshold causal model for clinical trials with departures from intended treatment

Statistics in Medicine

Volumn 18, Issue 13, 1999, Pages 1615-1626

  Albert, Jeffrey M ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL RESEARCH; DOSE RESPONSE; INFORMATION PROCESSING; PATIENT COMPLIANCE; PLANNING; SAMPLE; SIMULATION; STATISTICS; VARIANCE;

CAUSALITY; CD4 LYMPHOCYTE COUNT; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EFFECT MODIFIERS (EPIDEMIOLOGY); HIV INFECTIONS; HUMANS; INTERLEUKIN-2; MODELS, STATISTICAL; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS;

EID: 0033565315     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19990715)18:13<1615::AID-SIM161>3.0.CO;2-6     Document Type: Article

References (20)

1. Coronary Drug Research Group. 'Influence of adherence to treatment and response of cholesterol on mortality on the coronary drug project', New England Journal of Medicine, 302, 1038-1041 (1980).
2. Rubin, D. B. 'Estimating causal effects of treatments in randomized and nonrandomized studies', Journal of Educational Psychology, 66, 688-701 (1974).
3. Holland, P. 'Statistics and causal inference', Journal of the American Statistical Association, 81, 945-970 (1986).
4. Efron, B. and Feldman, D. 'Compliance as an explanatory variable in clinical trials', Journal of the American Statistical Association, 86, 9-26 (1991).
5. Goetghebeur, E. and Lapp, K. 'The effect of treatment compliance in a placebo-controlled trial: regression with unpaired data', Applied Statistics, 46, 351-364 (1997).
6. Robins, J. M. and Tsiatis, A. 'Correcting for non-compliance in randomized trials using rank-preserving structural failure time models', Communications in Statistics, 20, 2609-2631 (1991).
7. Pearl, J. 'Causal diagrams for empirical research', Biometrika, 82, 669-710 (1995).
8. Robins, J. M. 'Causal inference from complex longitudinal data', in Berkane, M. (ed), Latent Variables Modeling and Applications to Causality, Lecture Notes in Statistics (120), Springer-Verlag, New York, 1997.
9. Goetghebeur, E. and Molensberghs, G. 'Causal inference in a placebo-controlled clinical trial with binary outcome and ordered compliance', Journal of the American Statistical Association, 91, 928-934 (1996).
10. Rosenbaum, P. R. 'The consequences of adjustment for a concomitant variable that has been affected by treatment', Journal of the Royal Statistical Society, Series B, 147, 656-666 (1984).
11. Lee, Y. J., Ellenberg, J. H., Hirtz, D.G., and Nelson, K. B. 'Analysis of clinical trials by treatment actually received: is it really an option?', Statistics in Medicine, 10, 1595-1605 (1991).
12. Albert, J. M. and DeMets, D. L. 'On a model-based approach to estimating efficacy in clinical trials', Statistics in Medicine, 13, 2323-2335 (1994).
13. Kovacs, J. A., Vogel, S., Albert, J. M., Falloon, J., Davey, R. T., Walker, R. E., Polis, M. A., Spooner, K., Metcalf, J. A., Baseler, M., Fyfe, G. and Lane, H. C. 'Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus', New England Journal of Medicine, 335, 1350-1356 (1996).
14. Royall, R. M. Statistical Evidence: A Likelihood Paradigm, Chapman and Hall, New York, 1997.
15. Efron, B. and Tibshirani, R. An Introduction to the Bootstrap, Chapman and Hall, New York, 1993.
16. Rubin, D. B. 'Statistical matching using file concatenation with adjusted weights and multiple imputations', Journal of Business and Economic Statistics, 4, 87-94 (1986).
17. Heitjan, D. F. and Landis, J. R. 'Assessing secular trends in blood pressure: a multiple-imputation approach', Journal of the American Statistical Association, 89, 750-759 (1994).
18. Rosenbaum, P. R. Observational Studies, Springer-Verlag, New York, 1995.
19. Welsh, A. H. Aspects of Statistical Inference, Wiley, New York, 1996, pp. 688-701.
20. Albert, J. M. 'Accounting for noncompliance in the design of clinical trials', Drug Information Journal, 31, 157-165 (1997).